Search results
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition - KVIA
ABC 7 El Paso· 5 days agoBy MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — The Federal Trade Commission is challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic. Tuesday ...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
WCBD-TV Charleston· 5 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
Headache, Migraine, and Antiepileptic Drugs During Pregnancy
Medscape· 6 days agoChristoph Diener provides recent updates on headache in children, migraine drugs, and antiepileptic...
Janssen adopts J&J name as part of global rebranding effort
Pharmaceutical Technology via Yahoo Finance· 5 days agoAs part of the changes, the company also unveiled a new logo. Last year, GSK rebranded as it...
Women need not fear menopause hormone drugs, major health study finds
Anchorage Daily News· 5 days agoMore than two decades ago, the shocking results of a major women’s health study challenged the...
Wall Street stocks end mostly down while dollar slides after Fed decision
AFP via Yahoo Finance· 4 days agoWall Street stocks finished a choppy session mostly lower while the dollar retreated Wednesday after...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 6 days agoThe FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, AstraZeneca, ...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
ABC 26 New Orleans· 5 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press Finance via Yahoo Finance· 5 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 3 days agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...